Lupeol 100 mg | 99.31%
TargetMol
Lupeol is a novel androgen receptor inhibitor with anti-inflammatory and antioxidant activity.
More Information Supplier PageLupeol
Search Results
Astragaloside IV 10 mg | 98.85%
TargetMol
Astragaloside IV, an active component isolated from Astragalus membranaceus, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells. Astragaloside IV is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine.1 It dose-dependently inhibits human […]
More Information Supplier PageAstragaloside IV
Astragaloside IV 25 mg | 98.85%
TargetMol
Astragaloside IV, an active component isolated from Astragalus membranaceus, suppresses the activation of ERK1/2 and JNK, and downregulates matrix metalloproteases (MMP)-2, (MMP)-9 in MDA-MB-231 breast cancer cells. Astragaloside IV is a bioactive saponin first isolated from the dried plant roots of the genus Astragalus, which is used in traditional Chinese medicine.1 It dose-dependently inhibits human […]
More Information Supplier PageAstragaloside IV
PF 03716556 5 mg | 99.68%
TargetMol
PF 3716556, an effective and specific P-CAB (potassium-competitive acid blocker), is utilized for the treatment of gastroesophageal reflux disease.
More Information Supplier PagePF 03716556
PD153035 200 mg | 98.00%
TargetMol
PD153035 hydrochloride is an effective and selective inhibitor of EGFR (Ki/IC50: 5.2/29 pM, in cell-free assays); little inhibitory against FGFR, PGDFR, InsR, CSF-1 and Src.
More Information Supplier PagePD153035
PD153035 100 mg | 98.00%
TargetMol
PD153035 hydrochloride is an effective and selective inhibitor of EGFR (Ki/IC50: 5.2/29 pM, in cell-free assays); little inhibitory against FGFR, PGDFR, InsR, CSF-1 and Src.
More Information Supplier PagePD153035
Tiplaxtinin 25 mg | Purity Not Available
TargetMol
Tiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
More Information Supplier PageTiplaxtinin
Tiplaxtinin 2 mg | Purity Not Available
TargetMol
Tiplaxtinin(PAI-039) is a selective and orally efficacious inhibitor of plasminogen activator inhibitor-1 (PAI-1) with IC50 of 2.7 uM.
More Information Supplier PageTiplaxtinin
AVN-944 1 mg | 98.00%
TargetMol
AVN-944(VX-944) is a selective, noncompetitive inhibitor of human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2.
More Information Supplier PageAVN-944
AZD2858 2 mg | 98.00%
TargetMol
AZD2858 is a selective GSK-3 inhibitor, inhibiting tau phosphorylation at the S396 site and activating Wnt signaling pathway.
More Information Supplier PageAZD2858
